UPDATE: Credit Suisse Downgrades Solazyme on Production Delays, Weak Margin Outlook

In a report published Wednesday, Credit Suisse analyst Edward Westlake downgraded the rating on Solazyme (NASDAQ: SZYM ) from Outperform to Neutral, and lowered the price target from $17.00 to $12.00. In the report, Credit Suisse noted, “We downgrade our rating to Neutral (from Outperform) as shares will likely be